30 completed. 30 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 30 | Completed 30 |
| Phase 2 | 3 | Completed 3 |
Follow Ulcer: new trials by email Literature Review of Ulcer trials Research Report on Ulcer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective Study on the Therapeutic Outcomes of Mebo and Tantum Verde in Patients With Oral Mucositis MEBO Wound Ointment (MEBO), Tantum Verde® mouthwash - Oral Mucositis (Ulcerative) Due to Radiation | Phase 3 | Completed | Cairo University | 36 | 2023-03-01 | 2025-09-22 |
| Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2) NL003, Normal Saline - Arterial Occlusive Disease, Ischemia | Phase 3 | Completed | Beijing Northland Biotech. Co., Ltd. | 242 | 2019-08-28 | 2024-09-20 |
| Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1) NL003, Normal Saline - Arterial Occlusive Disease, Ischemia | Phase 3 | Completed | Beijing Northland Biotech. Co., Ltd. | 302 | 2019-08-02 | 2024-09-19 |
| To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis Ozanimod, Placebo - Colitis, Ulcerative | Phase 3 | Completed | Celgene | 198 | 2019-06-03 | 2025-10-15 |
| Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients Cisplatin, Intensity Modulated Radiation Therapy, Ulinastatin - Oral Mucositis (Ulcerative) Due to Radiation | Phase 3 | Completed | Sun Yat-sen University | 179 | 2018-01-30 | 2026-05-07 |
| A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan adalimumab - Pyoderma Gangrenosum | Phase 3 | Completed | AbbVie | 22 | 2017-10-27 | 2021-03-09 |
| Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers Intrastromal voriconazole, Natamycin - Corneal Ulcer, Fungal Keratitis | Phase 3 | Completed | University of California, San Francisco | 70 | 2016-09-01 | 2025-09-25 |
| Cross-linking for Corneal Ulcers Treatment Trial Corneal Cross-linking, Anti Fungal Drug - Corneal Ulcer, Infectious Keratitis | Phase 3 | Completed | University of California, San Francisco | 147 | 2015-11-01 | 2025-06-18 |
| Clinical Efficacy of Platelet Gel From Cord Blood for the Treatment of Diabetic Foot Ulcers Allogeneic cord blood platelet gel-CBPG, Standard Local Medications-SLM - Diabetic Foot Ulcers | Phase 3 | Completed | Centro Nazionale Sangue | 50 | 2015-01-01 | 2017-07-21 |
| Efficacy & Safety of Pedyphar Ointment in Diabetic Foot Ulcer Treatment Pedyphar Ointment, Panthenol - Diabetic Foot Ulcer | Phase 3 | Completed | European Egyptian Pharmaceutical Industries | 80 | 2013-04-01 | 2015-03-05 |
| Evaluate Misoprostol for the Healing of Small Bowel Ulcers in Low-dose Aspirin Users Complicated by Small Bowel Bleeding Misoprostol, Placebo - Ulcer Hemorrhage | Phase 2 / Phase 3 | Completed | Chinese University of Hong Kong | 82 | 2013-04-01 | 2019-01-31 |
| Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2 HP802-247, Vehicle - Venous Leg Ulcers | Phase 3 | Completed | Healthpoint | 155 | 2012-11-01 | 2017-07-26 |
| Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers HP-802-247, Vehicle - Venous Leg Ulcers | Phase 3 | Completed | Healthpoint | 447 | 2012-08-01 | 2016-03-14 |
| Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients macitentan 3mg, macitentan 10mg, placebo - Systemic Sclerosis, Ulcers | Phase 3 | Completed | Actelion | 289 | 2011-12-01 | 2015-01-06 |
| Sildenafil Effect on Digital Ulcer Healing in sClerodErma SEDUCE STUDY Sildenafil, placebo - Systemic Scleroderma | Phase 3 | Completed | University Hospital, Lille | 84 | 2010-11-01 | 2026-05-14 |
| Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing Mepilex Border Ag - Inflammation, Burns | Phase 3 | Completed | Molnlycke Health Care AB | 27 | 2010-09-01 | 2013-03-08 |
| Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis Budesonide, Placebo - Proctitis, Proctosigmoiditis | Phase 3 | Completed | Bausch Health Americas, Inc. | 281 | 2009-11-20 | 2019-08-14 |
| Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis Budesonide, Placebo - Proctitis, Proctosigmoiditis | Phase 3 | Completed | Bausch Health Americas, Inc. | 265 | 2009-11-17 | 2019-08-14 |
| A BE Study Comparing Mesalamine 400 mg to ASACOL® 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis Placebo, Mesalamine - Mild to Moderate Ulcerative Colitis | Phase 3 | Completed | EMET Pharmaceuticals, LLC | 2008-01-01 | 2010-01-08 | |
| Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers HZT-501, Ibuprofen - Peptic Ulcer | Phase 3 | Completed | Amgen | 627 | 2007-03-01 | 2024-12-16 |
Showing 20 of 30. Sign in to see all of them.
Diabetic Foot (8) · Colitis (5) · Colitis, Ulcerative (5) · Diabetes Mellitus (4) · Arterial Occlusive Diseases (2) · Arthritis (2) · Arthritis, Rheumatoid (2) · Chronic Limb-Threatening Ischemia (2) · Colonic Diseases (2) · Complex Regional Pain Syndromes (2) · Corneal Diseases (2) · Corneal Ulcer (2) · Digestive System Diseases (2) · Gastroenteritis (2)
Pathological Conditions, Signs and Symptoms (30) · Pathologic Processes (28) · Skin and Connective Tissue Diseases (16) · Skin Diseases (14) · Cardiovascular Diseases (12) · Vascular Diseases (12) · Skin Ulcer (11) · Leg Ulcer (10) · Diabetes Complications (8) · Diabetic Angiopathies (8) · Endocrine System Diseases (8) · Foot Ulcer (8) · Diabetic Neuropathies (7) · Digestive System Diseases (5) · Gastrointestinal Diseases (5)
Budesonide (2) · Ibuprofen (2) · Mesalamine (2) · Ofloxacin (2) · Saline Solution (2) · pexiganan (2) · Acyclovir (1) · Adalimumab (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Cisplatin (1) · Corneal Cross-Linking (1) · Famotidine (1) · Injections (1) · Misoprostol (1) · Moxifloxacin (1)
Abeona Therapeutics, Inc (2) · Amgen (2) · Bausch Health Americas, Inc. (2) · Beijing Northland Biotech. Co., Ltd. (2) · Healthpoint (2) · University of California, San Francisco (2) · AbbVie (1) · Actelion (1) · Bayer (1) · Cairo University (1) · Celgene (1) · Centers for Disease Control and Prevention (1) · Centro Nazionale Sangue (1) · Chinese University of Hong Kong (1) · Diabetica Solutions Inc. (1)
United States (12) · China (4) · Canada (3) · India (3) · Italy (3) · Japan (3) · Poland (3) · Russia (3) · Spain (3) · Bulgaria (2) · Colombia (2) · Croatia (2) · Egypt (2) · France (2) · Germany (2)
Herbert B Slade, MD (2) · Paul Litka, MD (2) · Robert Kirsner, MD (2) · Tommy Lee, MSHS (2) · William Marston, MD (2) · Arturo Orduz, MD (1) · Barbara Latenser, MD (1) · C. Mauli Agrawal, Ph.D. (1) · Carlos A Calderon, PhD (1) · Changwei Liu, MD (1)
PMID 18990064, PMID 25644096, PMID 26165391, PMID 27416045, PMID 29037354, PMID 15504999, PMID 17897470, PMID 18601587, PMID 19064169, PMID 19128245, PMID 19152653, PMID 19170984, PMID 19424751, PMID 19715417, PMID 20443734, PMID 20873963, PMID 21896561, PMID 23180507, PMID 23736928, PMID 2403699, PMID 25995322, PMID 27163986, PMID 29966612, PMID 31619359, PMID 31786695, PMID 32557558, PMID 33031809, PMID 33079921, PMID 35024776, PMID 35044972, PMID 3753059, PMID 42427283